Illumina, Inc.

ILMNNASDAQHealthcare● Active

$157.55

$-4.77(-2.94%)

Market Cap$23.8B

P/E Ratio—

52W High$172.49

52W Low$81.76

Avg Volume1.6M

Open$162.71

Beta1.49

Free Cash Flow Financials Revenue

Illumina, Inc. (ILMN) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ILMN · free cash flow · updated Jun 8, 2026

Core FCF metrics

ILMN · FCF · TTM · margin & CAGR

Free cash flow was $931.0M for FY2025 (fiscal year ending 2025-12-28), up 31.3% year-over-year The FCF margin was 21.5%. Five-year CAGR stands at +0.9%.

FY2025 Free Cash Flow$931.0M▲ +31.3% YoY

Trailing 12M (TTM)$989.0Mtrailing 4 quarters sum

FCF Margin21.5%$931.0M ÷ revenue

3-Year CAGR+106.3%FY2022 → FY2025

5-Year CAGR+0.9%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ILMN · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.08B(148M)$931.0M▲ +31.3%21.5%

FY2024$837.0M(128M)$709.0M▲ +151.4%16.2%

FY2023$478.0M(195M)$282.0M▲ +166.0%6.3%

FY2023$392.0M(286M)$106.0M▼ 68.5%2.3%

FY2022$545.0M(208M)$337.0M▼ 62.2%7.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ILMN · P/FCF · FCF yield · FCF per share

Illumina, Inc. (ILMN) trades at a FCF yield of 4.14% and a price-to-free-cash-flow ratio of 24.7x. FCF per share stands at $6.38, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

4.14%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$6.38

TTM FCF ÷ Shares Outstanding

Price / FCF

x24.7

Share Price ÷ FCF per Share

EV / FCF (TTM)

x25.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-28

Cash flow statement summary

ILMN · cash flow statement · operating / investing / financing

For FY2025, Illumina, Inc. generated $1.08B in operating cash flow and spent 148M in capital expenditures, yielding $931.0M in free cash flow.

Operating Activities

+$1.08B

Cash from core business operations

2025-12-28

Investing Activities

−$55.0M

CapEx, acquisitions & investments

2025-12-28

Financing Activities

−$744.0M

Buybacks, dividends & debt

2025-12-28

FCF FormulaOperating CF ($1.08B) − |CapEx| (148M) = FCF ($931.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ILMN vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Illumina, Inc.YOU

ILMN

$931.0M+31.3%21.5%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Illumina, Inc. (ILMN) reported free cash flow of $931.0M for FY2025 (fiscal year ending 2025-12-28), up 31.3% year-over-year. The FCF margin was 21.5%.

Based on available data, Illumina, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $931.0M in FY2025. The 5-year CAGR stands at +0.9%.

Illumina, Inc.'s FCF yield is 4.14% and price-to-FCF ratio is 24.7x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ILMN free cash flow · 8 questions

Illumina, Inc. free cash flow was $931.0M for FY2025, up 31.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $989.0M.

ILMN free cash flowILMN FCFILMN FCF 2025ILMN free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Illumina, Inc. · Illumina, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026